Potential applications and performance of machine learning techniques and algorithms in clinical practice: A
Ezekwesiri Michael Nwanosike1, Barbara R Conway1, Hamid A Merchant1
1Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate Huddersfield HD1 3DH, West Yorkshire, United Kingdom.
Machine learning (ML) algorithms show promise in clinical settings, with XGBoost being a top performer. However, further validation and improved quality standards are needed for widespread clinical adoption.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Clinical Decision Support Systems
Background:
- Machine learning (ML) algorithms offer potential solutions for diverse clinical challenges, including diagnosis, prognosis, and treatment recommendations.
- The integration of ML into clinical practice is rapidly advancing, necessitating a comprehensive review of its current performance and implementation status.
Purpose of the Study:
- To systematically review and evaluate the performance of machine learning algorithms in clinical practice.
- To assess the progress and identify key ML algorithms and application areas in healthcare.
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, MEDLINE, Scopus, Google Scholar, Cochrane Library, WHO Covid-19) for articles published between January 2011 and October 2021.
- Studies involving human subjects, ML techniques in clinical practice, and reporting performance metrics were included.
Main Results:
- Out of 873 unique articles, 36 were included. XGBoost (extreme gradient boosting) demonstrated high potential (7 studies), followed by random forest, logistic regression, and support vector machines (5 studies each).
- Outcome prediction was the most common application (33 studies), particularly for inflammatory diseases (7 studies), cancer, and neuropsychiatric disorders (5 studies each).
- While most studies met quality criteria (TRIPOD checklist), none achieved a 'low' bias rating (PROBAST checklist), and only three demonstrated actual clinical deployment.
Conclusions:
- Machine learning (ML) shows significant potential as a clinical decision support tool.
- Further research is required to validate ML algorithms for clinical use, focusing on enhancing quality, transparency, and interpretability to facilitate broader acceptance.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Current Trends in Nursing II
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Statistical Software for Data Analysis and Clinical Trials


